Transmitter-replacement Therapy in Alzheimer's Disease Using Intracerebroventricular Infusions of Receptor Agonists
Serge Gauthier(Texas Instruments (France)), Yves Robitaille(Montreal Neurological Institute and Hospital), Louise Gauthier(McGill University), Rémi Quirion(McGill University), Jean‐Martin Beaulieu(University of Toronto), Mary Gauvin(Montreal Neurological Institute and Hospital), Roberta M. Palmour(Memorial), Gunilla Carlsson(Allegheny Intermediate Unit), Frank R. Ervin(Memorial), J. P. Henry(Memorial), Richard Leblanc, Rémi W. Bouchard(Hôpital de l'Enfant-Jésus), Dolly Dastoor(Douglas College)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
November 1, 1986
Cited by 22
Related Papers
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
|Pharmacological Reviews|2011|2.7k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Mild cognitive impairment: a concept in evolution
|Journal of Internal Medicine|2014|1.7k